Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
36.25
+1.09 (3.10%)
At close: Jul 3, 2025, 1:00 PM
36.25
0.00 (0.00%)
After-hours: Jul 3, 2025, 1:01 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $221.68 million as of July 3, 2025. Its market cap has increased by 1,248.80% in one year.
Market Cap
221.68M
Enterprise Value
167.12M
1-Year Change
1,248.80%
Ranking
Category
Stock Price
$36.25
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $221.68M, a decrease of -19.73%. That is a compound annual growth rate of -3.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 697.81B |
Johnson & Johnson | 374.26B |
AbbVie | 337.65B |
Novo Nordisk | 306.99B |
UnitedHealth Group | 283.79B |
Novartis AG | 242.04B |
Abbott Laboratories | 234.03B |
AstraZeneca | 221.11B |